Hagmann WK - Search Results

1

Substituted imidazoles as glucagon receptor antagonists.

Chang LL, Sidler KL, Cascieri MA, de Laszlo S, Koch G, Li B, MacCoss M, Mantlo N, O'Keefe S, Pang M, Rolando A, Hagmann WK. Chang LL, et al. Among authors: hagmann wk. Bioorg Med Chem Lett. 2001 Sep 17;11(18):2549-53. doi: 10.1016/s0960-894x(01)00498-x. Bioorg Med Chem Lett. 2001. PMID: 11549467

2

Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding.

Lanza TJ, Durette PL, Rollins T, Siciliano S, Cianciarulo DN, Kobayashi SV, Caldwell CG, Springer MS, Hagmann WK. Lanza TJ, et al. Among authors: hagmann wk. J Med Chem. 1992 Jan 24;35(2):252-8. doi: 10.1021/jm00080a008. J Med Chem. 1992. PMID: 1310118

3

Orally active beta-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinones.

Shah SK, Dorn CP Jr, Finke PE, Hale JJ, Hagmann WK, Brause KA, Chandler GO, Kissinger AL, Ashe BM, Weston H, et al. Shah SK, et al. Among authors: hagmann wk. J Med Chem. 1992 Oct 16;35(21):3745-54. doi: 10.1021/jm00099a003. J Med Chem. 1992. PMID: 1433189

4

Glycolipids as host resistance stimulators.

Ponpipom MM, Hagmann WK, O'Grady LA, Jackson JJ, Wood DD, Zweerink HJ. Ponpipom MM, et al. Among authors: hagmann wk. J Med Chem. 1990 Feb;33(2):861-7. doi: 10.1021/jm00164a062. J Med Chem. 1990. PMID: 2299649

5

Mechanism of inhibition of human leucocyte elastase by monocyclic beta-lactams.

Chabin R, Green BG, Gale P, Maycock AL, Weston H, Dorn CP, Finke PE, Hagmann WK, Hale JJ, MacCoss M, et al. Chabin R, et al. Among authors: hagmann wk. Biochemistry. 1993 Aug 31;32(34):8970-80. doi: 10.1021/bi00085a031. Biochemistry. 1993. PMID: 8364042

6

Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitution.

Hagmann WK, Kissinger AL, Shah SK, Finke PE, Dorn CP, Brause KA, Ashe BM, Weston H, Maycock AL, Knight WB, et al. Hagmann WK, et al. J Med Chem. 1993 Mar 19;36(6):771-7. doi: 10.1021/jm00058a015. J Med Chem. 1993. PMID: 8459404

7

Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.

Esser CK, Bugianesi RL, Caldwell CG, Chapman KT, Durette PL, Girotra NN, Kopka IE, Lanza TJ, Levorse DA, MacCoss M, Owens KA, Ponpipom MM, Simeone JP, Harrison RK, Niedzwiecki L, Becker JW, Marcy AI, Axel MG, Christen AJ, McDonnell J, Moore VL, Olszewski JM, Saphos C, Visco DM, Hagmann WK, et al. Esser CK, et al. Among authors: hagmann wk. J Med Chem. 1997 Mar 14;40(6):1026-40. doi: 10.1021/jm960465t. J Med Chem. 1997. PMID: 9083493

8

Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor.

Cascieri MA, Koch GE, Ber E, Sadowski SJ, Louizides D, de Laszlo SE, Hacker C, Hagmann WK, MacCoss M, Chicchi GG, Vicario PP. Cascieri MA, et al. Among authors: hagmann wk. J Biol Chem. 1999 Mar 26;274(13):8694-7. doi: 10.1074/jbc.274.13.8694. J Biol Chem. 1999. PMID: 10085108 Free article.

9

Potent, orally absorbed glucagon receptor antagonists.

de Laszlo SE, Hacker C, Li B, Kim D, MacCoss M, Mantlo N, Pivnichny JV, Colwell L, Koch GE, Cascieri MA, Hagmann WK. de Laszlo SE, et al. Among authors: hagmann wk. Bioorg Med Chem Lett. 1999 Mar 8;9(5):641-6. doi: 10.1016/s0960-894x(99)00081-5. Bioorg Med Chem Lett. 1999. PMID: 10201821

10

Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.

Hagmann WK, Caldwell CG, Chen P, Durette PL, Esser CK, Lanza TJ, Kopka IE, Guthikonda R, Shah SK, MacCoss M, Chabin RM, Fletcher D, Grant SK, Green BG, Humes JL, Kelly TM, Luell S, Meurer R, Moore V, Pacholok SG, Pavia T, Williams HR, Wong KK. Hagmann WK, et al. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1975-8. doi: 10.1016/s0960-894x(00)00389-9. Bioorg Med Chem Lett. 2000. PMID: 10987430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page